Snapdeal on Friday responded to a First Information Report (FIR) lodged by the Mumbai Police against the e-commerce major for allegedly violating Food and Drugs Administration (FDA) norms by selling medicines including prescription drugs online.
"Upon being notified of any such products, we delist the products and take appropriate action against such seller. In this matter, we are assisting the FDA team in this investigation and we will continue to do so," a statement released by the company said.
"We have already delisted the products and said sellers and also stopped payment, in addition to providing all information to the FDA team as required by them," it said. Maharashtra's Food and Drugs Administration (FDA) had ordered the filing of the FIR against Snapdeal.com's CEO Kunal Bahl and directors of the company in the case.
Last month, the FDA had raided the company's premises in Mumbai in this regard. At that time, Snapdeal had said it was delisting the drugs from its portal and was assisting the regulator in the investigation.
The FDA had earlier issued a notice to the company and it was asked to furnish details of the drugs offered for sale, distribution and exhibited for sale on its website Snapdeal.com. The raid followed FDA receiving information that various medicines, including prescription drugs, were being sold online through Snapdeal.com.
As per the law, only a licensed retailer can sell drugs, and that too on the basis of prescription of a doctor, Kamble said, adding such type of online sale of drugs is not allowed as self medication can be harmful.
"Upon being notified of any such products, we delist the products and take appropriate action against such seller. In this matter, we are assisting the FDA team in this investigation and we will continue to do so," a statement released by the company said.
"We have already delisted the products and said sellers and also stopped payment, in addition to providing all information to the FDA team as required by them," it said. Maharashtra's Food and Drugs Administration (FDA) had ordered the filing of the FIR against Snapdeal.com's CEO Kunal Bahl and directors of the company in the case.
Last month, the FDA had raided the company's premises in Mumbai in this regard. At that time, Snapdeal had said it was delisting the drugs from its portal and was assisting the regulator in the investigation.
The FDA had earlier issued a notice to the company and it was asked to furnish details of the drugs offered for sale, distribution and exhibited for sale on its website Snapdeal.com. The raid followed FDA receiving information that various medicines, including prescription drugs, were being sold online through Snapdeal.com.
As per the law, only a licensed retailer can sell drugs, and that too on the basis of prescription of a doctor, Kamble said, adding such type of online sale of drugs is not allowed as self medication can be harmful.
0 Comment to "Snapdeal respond to FIR against online medicine sale!!!"
Post a Comment